How to join?

How to join?

The NCI is ready to expand the number of institutions participating in the CIRB Initiative. Through this expansion the CIRB will continue to develop the program, to explore a greater variety of issues, and to understand and respond to local IRB and investigator practices and concerns.

In order for your IRB to access CIRB review documents and to utilize the facilitated review mechanism, your institution must formally enroll in the Initiative. To join the Initiative, institutions

Related links:

Sample Adult and Pediatric CIRB Authorization Agreements
Sample Addendum
Benefits to participating institutions
Benefits to local investigators
Contact the CIRB

must have their own functioning IRB;
be actively enrolling patients in Cooperative Group/CTSU adult Phase III clinical trials - or - Pilot, Phase II or Phase III pediatric clinical trials;
possess a valid assurance (FWA)

When your institution is interested in joining, please contact the CIRB Administrative office through one of the methods described on the Contact Page on this web site. Information and sample documents can be sent in hard copy or electronically per your request. Copies of the NCI CIRB Authorization Agreement will be included in these materials. The Agreement is based on the OHRP sample text and also includes an Addendum which describes the division of responsibilities between NCI's Central IRB and local institutions. The Agreement for Institutions who plan on using CIRB reviews for adult trials only is available here. For Institutions who will use CIRB reviews for Pediatric trials only, the Agreement is available here. If your institution plans on utilizing CIRB reviews for both adult and pediatric trials, please contact the CIRB. A separate agreement will be sent to you.

Email CIRB contact to send your thoughts and questions to the CIRB.

						back to top